Subanesthetic ketamine: the way forward for pain management in sickle cell disease patients?
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Hematology"
DOI: 10.1080/17474086.2022.2131523
Abstract: ABSTRACT Introduction Patients with sickle cell disease (SCD) present recurrent episodes of acute pain, the hallmark of the disease, and some will also develop chronic pain. Currently, the treatment of SCD acute pain only targets… read more here.
Keywords: subanesthetic ketamine; acute pain; pain; cell disease ... See more keywords
Subanesthetic ketamine with an AMPAkine attenuates motor impulsivity in rats
Sign Up to like & getrecommendations! Published in 2021 at "Behavioural Pharmacology"
DOI: 10.1097/fbp.0000000000000623
Abstract: Supplemental Digital Content is available in the text. The concept of ‘impulse control’ has its roots in early psychiatry and today has progressed into a well-described, although poorly understood, multidimensional endophenotype underlying many neuropsychiatric disorders… read more here.
Keywords: control; subanesthetic ketamine; impulsivity; motor impulsivity ... See more keywords
Subanesthetic ketamine for pain management in hospitalized children, adolescents, and young adults: a single-center cohort study
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Pain Research"
DOI: 10.2147/jpr.s131156
Abstract: Background Subanesthetic doses of ketamine, an N-methyl-d-aspartate receptor antagonist used as an adjuvant to opioid for the treatment of pain in adults with acute and chronic pain, have been shown, in some instances, to improve… read more here.
Keywords: ketamine; ketamine pain; pain management; subanesthetic ketamine ... See more keywords